Cargando…
Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization
Hepatic insulin resistance is a hallmark feature of nonalcoholic fatty liver disease and type-2 diabetes and significantly contributes to systemic insulin resistance. Abnormal activation of nutrient and stress-sensing kinases leads to serine/threonine phosphorylation of insulin receptor substrate (I...
Autores principales: | Chen, Cheng, Gu, Lijie, Matye, David J., Clayton, Yung-Dai, Hasan, Mohammad Nazmul, Wang, Yifeng, Friedman, Jacob E., Li, Tiangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832973/ https://www.ncbi.nlm.nih.gov/pubmed/35115401 http://dx.doi.org/10.1073/pnas.2111737119 |
Ejemplares similares
-
Anticancer drug discovery by targeting cullin neddylation
por: Yu, Qing, et al.
Publicado: (2020) -
Targeting cullin neddylation for cancer and fibrotic diseases
por: He, Zhang-Xu, et al.
Publicado: (2023) -
Actions of Adenosine on Cullin Neddylation: Implications for Inflammatory Responses
por: Curtis, Valerie F., et al.
Publicado: (2014) -
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice
por: Hasan, Mohammad Nazmul, et al.
Publicado: (2023) -
Recruitment of the inhibitor Cand1 to the cullin substrate adaptor site mediates interaction to the neddylation site
por: Helmstaedt, Kerstin, et al.
Publicado: (2011)